| Financial Year |
March 31 2023 |
| Monetary Funds |
2,862,005,318.62 |
| Held-for-trading Financial Assets |
135,066,792.66 |
| Notes Receivable |
-- |
| Accounts Receivable |
860,541,254.43 |
| Advances to Suppliers |
294,097,952.61 |
| Other Receivables |
286,666,851.55 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
52,176,570.44 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,602,886,568.46 |
| Total Current Assets |
6,093,441,308.77 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
43,299,845.84 |
| Investment Properties |
-- |
| Fixed Assetes |
7,660,629,529.83 |
| Under-construction Projects |
1,098,084,239.16 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,551,851,574.19 |
| R&D expenses |
21,759,401.95 |
| Goodwill |
791,990,906.53 |
| Long-Term Deferred and Prepaid Expenses |
380,346,404.39 |
| Deferred Income Tax Assets |
166,687,899.26 |
| Other Non-Current Assets |
371,844,825.65 |
| Sub-Total of Non-Current Assets |
15,143,404,398.94 |
| Total Assets |
21,236,845,707.71 |
| Short-Term Loans |
3,333,827,072.05 |
| Trading Financial liabilities |
-- |
| Notes Payable |
119,633,686.51 |
| Accounts Payable |
2,918,604,052.10 |
| Accounts Received In Advance |
29,309,759.93 |
| Employee Compensation Payable |
191,431,279.48 |
| Taxes Payable |
189,413,904.18 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
665,102,498.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,115,005,303.62 |
| Other Current Liabilities |
113,392,182.52 |
| Sub-Total of Current Liabilities |
9,669,546,561.43 |
| Long-term Loans |
964,399,314.09 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
6,999,257.11 |
| Special Payable |
-- |
| Estimatied Liabilities |
42,338,659.88 |
| Deferred Income Tax Liabilities |
11,693,993.56 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,265,007,289.92 |
| Total Liabilities |
12,934,553,851.35 |
| Paid-In Capital(Or Share Stock) |
422,012,153.00 |
| Capital Surplus |
3,047,977,171.05 |
| Surplus Reserve |
573,005,318.08 |
| LESS:Treasury Stock |
127,075,970.62 |
| Undistributed Profits |
4,330,225,078.78 |
| Minority Stockholder's Interest |
35,590,180.83 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,266,701,675.53 |
| Owner's Equity（Stockholder's Equity） |
8,302,291,856.36 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
21,236,845,707.71 |
